Back to Search
JEFFREY CURTIS, M.D.
M.D.
Pulmonary Disease Physician
NPI: 1578649018Individual
Specialties, Licenses & Credentials
Critical Care Medicine (Internal Medicine) Physician
Internal Medicine — Critical Care Medicine
Code: 207RC0200X
4301-056149(MI)
Pulmonary Disease PhysicianPrimary
Internal Medicine — Pulmonary Disease
Code: 207RP1001X
4301-056149(MI)
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
4301056149(MI)
Clinical Trials (2)
2
Linked Trials
0
Recruiting
2
With Results
Research & Publications (20)
Activated Peripheral Blood B Cells in Rheumatoid Arthritis and Their Relationship to Anti-Tumor Necrosis Factor Treatment and Response: A Randomized Clinical Trial of the Effects of Anti-Tumor Necrosis Factor on B Cells.
PMID 34347945·Arthritis Rheumatol·2022
3-trial
Improvement of High-Density Lipoprotein Function in Patients With Early Rheumatoid Arthritis Treated With Methotrexate Monotherapy or Combination Therapies in a Randomized Controlled Trial.
PMID 27483410·Arthritis Rheumatol·2017
2-rct
Association of Triple Therapy With Improvement in Cholesterol Profiles Over Two-Year Followup in the Treatment of Early Aggressive Rheumatoid Arthritis Trial.
PMID 26606398·Arthritis Rheumatol·2016
3-trial
Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker.
PMID 27188329·Arthritis Res Ther·2016
2-rct
Serum cotinine as a biomarker of tobacco exposure and the association with treatment response in early rheumatoid arthritis.
PMID 22730343·Arthritis Care Res (Hoboken)·2012
2-rct
A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial.
PMID 22508468·Arthritis Rheum·2012
4-observational
[TNF inhibitors for treatment of rheumatoid arthritis].
PMID 19149036·Nihon Naika Gakkai Zasshi·2008
6-review
[Daily practice using the guidelines for prevention and treatment of osteoporosis. The effects of anti-TNF therapy on bone and joint manifestations in rheumatoid arthritis].
PMID 18677056·Clin Calcium·2008
6-review
Tyro3 receptor tyrosine kinases in the heterogeneity of apoptotic cell uptake.
PMID 19273223·Front Biosci (Landmark Ed)·2009
6-review
The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research.
PMID 17878463·Proc Am Thorac Soc·2007
6-review
Cell-mediated adaptive immune defense of the lungs.
PMID 16322591·Proc Am Thorac Soc·2005
4-observational
Enhancing antitumor immunity perioperatively: a matter of timing, cooperation, and specificity.
PMID 12707008·Am J Respir Cell Mol Biol·2003
7-preclinical
Subset-specific reductions in lung lymphocyte accumulation following intratracheal antigen challenge in endothelial selectin-deficient mice.
PMID 12193727·J Immunol·2002
7-preclinical
Lymphocyte-endothelial cell adhesive interactions in lung immunity: lessons from the murine response to particulate antigen.
PMID 10960661·Immunopharmacology·2000
6-review
Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.
PMID 19147616·Ann Rheum Dis·2010
4-observational
"Pathologic" fractures: should these be included in epidemiologic studies of osteoporotic fractures?
PMID 19184268·Osteoporos Int·2009
8-other
Improving the prediction of medication compliance: the example of bisphosphonates for osteoporosis.
PMID 19194337·Med Care·2009
8-other
Do physicians within the same practice setting manage osteoporosis patients similarly? Implications for implementation research.
PMID 19319619·Osteoporos Int·2009
4-observational
Population-based fracture risk assessment and osteoporosis treatment disparities by race and gender.
PMID 19551449·J Gen Intern Med·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1500 E MEDICAL CENTER DR
ANN ARBOR, MI 48109 - Phone
- (734) 647-9342
Quick Facts
- NPI
- 1578649018
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 1
- Clinical Trials
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile